Aelis Farma
Clinical-stage biopharmaceutical company developing treatments for brain and peripheral disorders involving the CB1 receptor.
About
Technology stack
detected 2026-06-19No comments yet. Be the first to share your take.
What does Aelis Farma do?
Aelis Farma is a clinical-stage biopharmaceutical company focused on developing novel treatments for brain and peripheral disorders by targeting the CB1 receptor. Their proprietary platform generates Signaling Specific inhibitors of the CB1 receptor (CB1-SSi), which mimic a natural brain defense mechanism to treat various neurological conditions without disrupting normal behavior. The company's lead candidates, AEF0117 and AEF0217, are in advanced clinical trials for cannabis use disorders and c…
How much funding has Aelis Farma raised?
Aelis Farma has raised a total of $54M in funding. The most recent round on record is Grant.
Where is Aelis Farma headquartered?
Aelis Farma is headquartered in Bordeaux, Nouvelle-Aquitaine, France.
When was Aelis Farma founded?
Aelis Farma was founded in 2013.
What industry does Aelis Farma operate in?
Aelis Farma operates in Biotechnology, Pharmaceuticals, Healthcare, Biotech, MedTech, HealthTech.
How many employees does Aelis Farma have?
Aelis Farma has approximately 25 people on record.